New Patent application for Chronic Therapy
The company states that its chronic pain formulation are substantially free of delta-9-tetrahydrocannabinol(TCH), which minimizes its potential for abuse. It's a long way from a patent application to clinical trials and any data showing efficacy or safety of treatments for chronic pain. The current drug delivery effort were accelerated through the combination of proprietary [...]